pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB
S.L
S.L is a pharma organization headquartered in SAN DIEGO, CA, EU. It trades on NYSE under ticker CNTB. Primary therapeutic focus areas include Patency of the Ductus Arteriosus, Atopic Dermatitis, Chronic Rhinosinusitis Wi
SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
CBP-307
Phase 1 · small molecule · Healthy Adult Subjects
CBP-307 for Healthy Adult Subjects is a Phase 1 program (small_molecule) at S.L with 1 ClinicalTrials.gov record(s).
Internal code CBP-307CN004
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.L
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Healthy Adult Subjects
- Status
- completed
- Trials
- 1